Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative genomics on FGF20 orthologs.

Masuko Katoh1, Masaru Katoh

  • 1M&M Medical BioInformatics, Hongo 113-0033, Japan.

Oncology Reports
|June 10, 2005
PubMed
Summary

Fibroblast Growth Factor 20 (FGF20) is a gene with significant roles in cancer and neurodegenerative diseases. Comparative genomics reveals its conserved structure and regulatory elements across vertebrates, highlighting its potential in regenerative medicine and oncology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion molecules.

Frontiers in molecular medicine·2025
Same author

Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review).

International journal of molecular medicine·2024
Same author

Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation.

Frontiers in molecular medicine·2024
Same author

Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours.

Clinical and translational medicine·2024
Same author

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.

Nature reviews. Clinical oncology·2024
Same author

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.

Scientific reports·2024

Area of Science:

  • Comparative Genomics
  • Molecular Biology
  • Human Genetics

Background:

  • Human Fibroblast Growth Factor 20 (FGF20) was cloned and characterized, with subsequent identification by other research groups.
  • FGF20 is implicated in colorectal cancer via WNT/beta-catenin pathway activation.
  • FGF20 shows therapeutic potential for inflammatory bowel disease, oral mucositis, and Parkinson's disease.

Purpose of the Study:

  • To perform comparative genomics analyses on FGF20 orthologs across different species.
  • To investigate the evolutionary conservation and genomic organization of the FGF20 gene.
  • To identify conserved regulatory elements in the FGF20 promoter regions.

Main Methods:

  • Comparative genomics analysis of FGF20 orthologs.
  • Sequence identity comparison between human FGF20 and orthologs in zebrafish, Xenopus, rat, and mouse.
  • Analysis of gene linkage and conserved promoter regions, including transcription factor binding sites.

Main Results:

  • Zebrafish fgf20 gene structure and location identified.
  • High amino acid identity (75.5-76.9%) observed between human FGF20 and its vertebrate orthologs, indicating strong conservation.
  • Conserved regulatory elements, including TCF/LEF, EVI1, TGIF, PAX4, E47, and AREB6 binding sites, found in human and mouse FGF20 promoter regions.

Conclusions:

  • FGF20 orthologs are highly conserved among vertebrates.
  • The FGF20-EFHA2 locus and FGF9-EFHA1 locus represent paralogous regions in the human genome.
  • Conserved promoter elements suggest shared regulatory mechanisms for FGF20 across species, supporting its role in oncology and regenerative medicine.

Related Experiment Videos